Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
IMNM
IMNM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest IMNM ETF News Today | Earnings, Events & Price Alerts
IMNM News
Opaleye Management Exits Entire Stake in Immunome
4h ago
NASDAQ.COM
Immunome Reports FY Loss and Declining Revenue Amid Public Offering
1d ago
seekingalpha
Opaleye Management Sells Entire Stake in Immunome for $37.3 Million
4h ago
Fool
Redmile Group Increases Stake in Immunome
Feb 22 2026
Fool
Redmile Group Increases Immunome Holdings
Feb 22 2026
NASDAQ.COM
Wall Street Analysts Adjust Ratings
Feb 12 2026
Benzinga
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Globenewswire
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Newsfilter
Market Overview: Energy Stocks Show Strength
Feb 01 2026
Benzinga
IMNM Options Analysis: Put Contract Offers 27.5% YieldBoost
Jan 13 2026
NASDAQ.COM
Insider Buying Update for Friday, December 19: IMNM and S
Dec 19 2025
NASDAQ.COM
Initial Week of IMNM Options Trading for February 2026
Dec 19 2025
NASDAQ.COM
Immunome Prices 18.625M Share Offering at $21.50, Raising Approximately $400 Million
Dec 17 2025
Newsfilter
Immunome Prices 18.625M Shares at $21.50, Raising Approximately $400 Million
Dec 17 2025
Businesswire
Immunome Reveals Pricing for Public Common Stock Offering
Dec 17 2025
Yahoo Finance
Oncolytics Biotech Secures FDA Approval with 33% Efficacy for New Drug
Dec 16 2025
Newsfilter
Show More News
